Document is current
Any future updates will be listed below
-
Authors
Doaei, Saeid
Gholami, Somayeh
Rastgoo, Samira
Gholamalizadeh, Maryam
Bourbour, Fatemeh
Bagheri, Seyedeh Elaheh
Samipoor, Forough
Akbari, Mohammad Esmail
Shadnoush, Mahdi
Ghorat, Fereshteh
Mosavi Jarrahi, Seyed Alireza
Ashouri Mirsadeghi, Narjes
Hajipour, Azadeh
Joola, Parvin
Moslem, Alireza
Goodarzi, Mark O.
-
Clinical Trials BETA
Clinical trials referenced in this document:
irct20151226025699n3 at Iranian Registry of Clinical TrialsDocuments that mention this clinical trial
The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial
https://doi.org/10.1186/s12967-021-02795-5
- License Information
-
More Information
Article History
Received: 10 November 2020
Accepted: 18 March 2021
First Online: 29 March 2021
Declarations
:
: The study was approved by the ethics committee of Sabzevar University of Medical Sciences and Health Services, Khorasan Razavi, Iran (Ethical code: IR.MEDSAB.REC.1399.054). Furthermore, the necessary details of the project were explained clearly to the patients or their first-degree relatives and written informed consent was obtained from them before they joined the study. All participants were free to decide whether or not to participate or to withdraw at any time and for any reason without further penalty either personal or professional or affecting their future medical care.
: Not applicable.
: The authors declare that they have no competing interests.
